CAPN1 and proximal spinal muscular atrophy: Recent research however associates overactivated calpain-1 in the pathogenesis of SMA, suggesting the utility of calpain inhibition in SMA therapy (de la Fuente et al., 2019; de la Fuente et al., 2020).